1. Home
  2. FWDI vs CTMX Comparison

FWDI vs CTMX Comparison

Compare FWDI & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forward Industries Inc.

FWDI

Forward Industries Inc.

N/A

Current Price

$7.02

Market Cap

738.4M

Sector

Industrials

ML Signal

N/A

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$5.39

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FWDI
CTMX
Founded
1961
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
738.4M
596.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
FWDI
CTMX
Price
$7.02
$5.39
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$8.00
AVG Volume (30 Days)
730.1K
3.0M
Earning Date
02-12-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.22
EPS
N/A
0.24
Revenue
$18,187,525.00
$113,631,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$22.29
Revenue Growth
N/A
N/A
52 Week Low
$3.32
$0.40
52 Week High
$46.00
$6.15

Technical Indicators

Market Signals
Indicator
FWDI
CTMX
Relative Strength Index (RSI) 42.46 65.20
Support Level $7.08 $5.26
Resistance Level $8.00 $6.15
Average True Range (ATR) 0.56 0.42
MACD -0.06 0.10
Stochastic Oscillator 1.06 63.35

Price Performance

Historical Comparison
FWDI
CTMX

About FWDI Forward Industries Inc.

Forward Industries Inc is a provider of carrying and protective solutions. The company designs and distributes product protection for handheld electronic devices. Forward Industries sells soft-sided carrying cases for blood glucose diagnostic kits and portable consumer electronic devices such as tablets, personal computers, barcode Scanners, GPS devices, and others. The company operates in two segments, the OEM distribution segment sources and distributes carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic devices directly to OEMs; The design segment, provides a full spectrum of hardware and software product design and engineering services. The majority of revenue is generated from the Design segment.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: